Pacific Biosciences Of California (PACB) Total Debt Growth (1y) (2011 - 2023)
Pacific Biosciences Of California (PACB) Total Debt Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -0.50% |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -99.71% |
| Dec 31, 2022 | 4,362.49% |
| Dec 31, 2019 | 7.78% |
| Dec 31, 2018 | 7.51% |
| Sep 30, 2018 | 37.57% |
| Jun 30, 2018 | 35.25% |
| Mar 31, 2018 | 4.29% |
| Dec 31, 2017 | -15.34% |
| Sep 30, 2017 | -33.80% |
| Jun 30, 2017 | -32.62% |
| Mar 31, 2017 | -12.58% |
| Dec 31, 2016 | 7.75% |
| Sep 30, 2016 | 6.66% |
| Jun 30, 2016 | 6.38% |
| Mar 31, 2016 | 6.12% |
| Dec 31, 2015 | 6.84% |
| Sep 30, 2015 | 6.43% |
| Jun 30, 2015 | 6.22% |
| Mar 31, 2015 | 6.02% |
| Dec 31, 2014 | 4.83% |